His primary areas of study are Dengue fever, Dengue virus, Immunology, Virology and Serotype. Robert V. Gibbons studied Dengue fever and Disease that intersect with Immune system and Cross immunity. His Dengue virus research includes elements of Veterinary medicine, Vector and Epidemiology.
While the research belongs to areas of Immunology, Robert V. Gibbons spends his time largely on the problem of Incidence, intersecting his research to questions surrounding Mortality rate and Force of infection. His Viral disease, Virus and Aedes study in the realm of Virology interacts with subjects such as Spatio temporal clustering and High transmission. His studies deal with areas such as Prospective cohort study and Pediatrics as well as Serotype.
The scientist’s investigation covers issues in Dengue fever, Virology, Dengue virus, Immunology and Virus. He has researched Dengue fever in several fields, including Incidence, Epidemiology and Pediatrics. He combines subjects such as Antibody and Hepatitis E with his study of Virology.
His research integrates issues of Secondary infection, Neutralizing antibody, Serotype, Transmission and Flavivirus in his study of Dengue virus. His study in Serotype is interdisciplinary in nature, drawing from both Titer and Viremia. Robert V. Gibbons interconnects Internal medicine and Subclinical infection in the investigation of issues within Immunology.
Robert V. Gibbons mainly focuses on Dengue fever, Dengue virus, Virology, Immunology and Vaccination. His Dengue fever research integrates issues from Transmission, Epidemiology and Disease. His Dengue virus study combines topics from a wide range of disciplines, such as Secondary infection, Spatial epidemiology, Convalescence and Spatial ecology.
His Virology research includes themes of Men who have sex with men and Immune system. His Immunology research focuses on Internal medicine and how it connects with Influenza-like illness, Cardiology and Serology. His work deals with themes such as Seroconversion, Immunization and Pediatrics, which intersect with Vaccination.
His scientific interests lie mostly in Dengue fever, Dengue virus, Immunology, Virology and Internal medicine. His research in Dengue fever focuses on subjects like Biological dispersal, which are connected to Spatial epidemiology, Spatial ecology and Bioinformatics. His Dengue virus research is multidisciplinary, incorporating elements of Epidemiology and Disease.
In general Immunology study, his work on Vaccination, Inflammation and Microglia often relates to the realm of Astrocyte, thereby connecting several areas of interest. His works in Serotype and Neutralizing antibody are all subjects of inquiry into Virology. His Internal medicine study combines topics in areas such as Alphavirus infection and Serology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Dengue: an escalating problem
Robert V Gibbons;David W Vaughn.
BMJ (2002)
A Comparison of Physicians’ and Patients’ Attitudes Toward Pharmaceutical Industry Gifts
Robert V. Gibbons;Robert V. Gibbons;Robert V. Gibbons;Frank J. Landry;Frank J. Landry;Denise L. Blouch;David L. Jones.
Journal of General Internal Medicine (1998)
Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006.
Jessica R. Fried;Robert V. Gibbons;Siripen Kalayanarooj;Stephen J. Thomas.
PLOS Neglected Tropical Diseases (2010)
Analysis of Repeat Hospital Admissions for Dengue to Estimate the Frequency of Third or Fourth Dengue Infections Resulting in Admissions and Dengue Hemorrhagic Fever, and Serotype Sequences
Robert V. Gibbons;Siripen Kalanarooj;Richard G. Jarman;Ananda Nisalak.
American Journal of Tropical Medicine and Hygiene (2007)
The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia. A meta-analysis.
Jeffrey L. Jackson;Robert Gibbons;Gregg Meyer;Lisa Inouye.
JAMA Internal Medicine (1997)
Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity
Nicholas G. Reich;Nicholas G. Reich;Sourya Shrestha;Aaron A. King;Aaron A. King;Pejman Rohani;Pejman Rohani.
Journal of the Royal Society Interface (2013)
Natural history of plasma leakage in dengue hemorrhagic fever: a serial ultrasonographic study.
Anon Srikiatkhachorn;Anchalee Krautrachue;Warangkana Ratanaprakarn;Lawan Wongtapradit.
Pediatric Infectious Disease Journal (2007)
Prophylaxis against rabies
Charles E. Rupprecht;Robert V. Gibbons.
The New England Journal of Medicine (2004)
The Impact of the Demographic Transition on Dengue in Thailand: Insights from a Statistical Analysis and Mathematical Modeling
Derek A. T. Cummings;Sopon Iamsirithaworn;Justin T. Lessler;Aidan McDermott.
PLOS Medicine (2009)
Human infection due to recombinant vaccinia-rabies glycoprotein virus.
Charles E. Rupprecht;Leonard Blass;Kathy Smith;Lillian A. Orciari.
The New England Journal of Medicine (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Walter Reed Army Institute of Research
United States Department of the Army
Queen Sirikit National Institute of Child Health
University of Rhode Island
University of Massachusetts Medical School
Mahidol University
University of Florida
University of Oxford
University of California, Davis
GlaxoSmithKline (United Kingdom)
University of Science and Technology of China
Carnegie Mellon University
Teagasc - The Irish Agriculture and Food Development Authority
IBM (United States)
North Carolina State University
University of Massachusetts Medical School
Pennsylvania State University
University of Coimbra
University of Michigan–Ann Arbor
Indiana University
The University of Texas Health Science Center at Houston
University of Queensland
University of Sydney
Children's Hospital of Philadelphia
Brigham and Women's Hospital
Harvard University